vs
Side-by-side financial comparison of Canopy Growth Corp (CGC) and MEDIFAST INC (MED). Click either name above to swap in a different company.
MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $54.4M, roughly 1.4× Canopy Growth Corp). On growth, Canopy Growth Corp posted the faster year-over-year revenue change (-0.3% vs -36.9%). Over the past eight quarters, Canopy Growth Corp's revenue compounded faster (1.2% CAGR vs -34.4%).
Canopy Growth Corporation, formerly Tweed Marijuana Inc., is a cannabis company based in Smiths Falls, Ontario.
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
CGC vs MED — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $54.4M | $75.1M |
| Net Profit | $-45.7M | — |
| Gross Margin | 28.8% | 69.4% |
| Operating Margin | -35.3% | -10.4% |
| Net Margin | -84.0% | — |
| Revenue YoY | -0.3% | -36.9% |
| Net Profit YoY | 48.6% | — |
| EPS (diluted) | — | $-1.64 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $54.4M | $75.1M | ||
| Q3 25 | $48.7M | $89.4M | ||
| Q2 25 | $52.7M | $105.6M | ||
| Q1 25 | $47.5M | $115.7M | ||
| Q4 24 | $54.6M | $119.0M | ||
| Q3 24 | $46.0M | $140.2M | ||
| Q2 24 | $48.3M | $168.6M | ||
| Q1 24 | $53.1M | $174.7M |
| Q4 25 | $-45.7M | — | ||
| Q3 25 | $-1.2M | $-2.3M | ||
| Q2 25 | $-30.3M | $2.5M | ||
| Q1 25 | — | $-772.0K | ||
| Q4 24 | $-89.0M | — | ||
| Q3 24 | $-93.7M | $1.1M | ||
| Q2 24 | $-92.8M | $-8.2M | ||
| Q1 24 | — | $8.3M |
| Q4 25 | 28.8% | 69.4% | ||
| Q3 25 | 32.8% | 69.5% | ||
| Q2 25 | 25.0% | 72.6% | ||
| Q1 25 | 16.2% | 72.8% | ||
| Q4 24 | 32.2% | 74.1% | ||
| Q3 24 | 34.7% | 75.4% | ||
| Q2 24 | 34.8% | 73.2% | ||
| Q1 24 | 21.3% | 72.8% |
| Q4 25 | -35.3% | -10.4% | ||
| Q3 25 | -25.3% | -4.6% | ||
| Q2 25 | -31.4% | -1.0% | ||
| Q1 25 | — | -1.1% | ||
| Q4 24 | -31.9% | 0.6% | ||
| Q3 24 | -72.9% | 1.5% | ||
| Q2 24 | -44.0% | -4.7% | ||
| Q1 24 | — | 4.5% |
| Q4 25 | -84.0% | — | ||
| Q3 25 | -2.5% | -2.5% | ||
| Q2 25 | -57.6% | 2.3% | ||
| Q1 25 | — | -0.7% | ||
| Q4 24 | -163.0% | — | ||
| Q3 24 | -203.7% | 0.8% | ||
| Q2 24 | -192.0% | -4.8% | ||
| Q1 24 | — | 4.8% |
| Q4 25 | — | $-1.64 | ||
| Q3 25 | — | $-0.21 | ||
| Q2 25 | — | $0.22 | ||
| Q1 25 | — | $-0.07 | ||
| Q4 24 | — | $0.08 | ||
| Q3 24 | — | $0.10 | ||
| Q2 24 | — | $-0.75 | ||
| Q1 24 | — | $0.76 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $271.1M | $167.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $553.5M | $198.9M |
| Total Assets | $807.5M | $248.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $271.1M | $167.3M | ||
| Q3 25 | $217.6M | $173.5M | ||
| Q2 25 | $104.8M | $162.7M | ||
| Q1 25 | $96.0M | $164.6M | ||
| Q4 24 | $130.2M | $162.3M | ||
| Q3 24 | $168.8M | $170.0M | ||
| Q2 24 | $142.3M | $163.5M | ||
| Q1 24 | $148.5M | $156.4M |
| Q4 25 | $553.5M | $198.9M | ||
| Q3 25 | $537.3M | $214.7M | ||
| Q2 25 | $357.0M | $216.0M | ||
| Q1 25 | $355.7M | $211.0M | ||
| Q4 24 | $431.8M | $210.1M | ||
| Q3 24 | $372.1M | $207.3M | ||
| Q2 24 | $389.0M | $205.3M | ||
| Q1 24 | $365.3M | $211.0M |
| Q4 25 | $807.5M | $248.0M | ||
| Q3 25 | $781.0M | $268.2M | ||
| Q2 25 | $660.4M | $269.3M | ||
| Q1 25 | $669.9M | $280.0M | ||
| Q4 24 | $849.9M | $284.2M | ||
| Q3 24 | $899.6M | $291.2M | ||
| Q2 24 | $938.9M | $293.5M | ||
| Q1 24 | $949.2M | $302.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-5.3M |
| Free Cash FlowOCF − Capex | — | $-6.6M |
| FCF MarginFCF / Revenue | — | -8.8% |
| Capex IntensityCapex / Revenue | — | 1.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-5.3M | ||
| Q3 25 | — | $12.1M | ||
| Q2 25 | $-7.5M | $-3.4M | ||
| Q1 25 | $-121.0M | $3.4M | ||
| Q4 24 | — | $-4.9M | ||
| Q3 24 | — | $9.1M | ||
| Q2 24 | $-37.8M | $13.1M | ||
| Q1 24 | $-205.8M | $7.3M |
| Q4 25 | — | $-6.6M | ||
| Q3 25 | — | $10.8M | ||
| Q2 25 | $-8.5M | $-4.8M | ||
| Q1 25 | $-128.9M | $1.9M | ||
| Q4 24 | — | $-7.2M | ||
| Q3 24 | — | $7.7M | ||
| Q2 24 | $-40.7M | $11.1M | ||
| Q1 24 | $-208.3M | $5.4M |
| Q4 25 | — | -8.8% | ||
| Q3 25 | — | 12.0% | ||
| Q2 25 | -16.1% | -4.5% | ||
| Q1 25 | -271.5% | 1.6% | ||
| Q4 24 | — | -6.1% | ||
| Q3 24 | — | 5.5% | ||
| Q2 24 | -84.1% | 6.6% | ||
| Q1 24 | -392.1% | 3.1% |
| Q4 25 | — | 1.8% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | 1.8% | 1.3% | ||
| Q1 25 | 16.6% | 1.3% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 1.0% | ||
| Q2 24 | 5.9% | 1.1% | ||
| Q1 24 | 4.7% | 1.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -1.36× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 8.04× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.88× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CGC
| Other | $24.0M | 44% |
| Canadian Adult Use Cannabis | $22.9M | 42% |
| International Markets Cannabis | $6.2M | 11% |
| Other Geographical Area | $1.2M | 2% |
MED
Segment breakdown not available.
